[1] Royal Marsden Hosp NHS Fdn Trust, Dept Gynaecol, London, England
[2] Inst Canc Res, London, England
[3] Univ Oklahoma, Stephenson Oklahoma Canc Ctr, Dept Obstet & Gynecol, Oklahoma City, OK USA
[4] Univ Milano Bicocca, Gynecol Oncol Dept, Milan, Italy
[5] Ist Europeo Oncol, Milan, Italy
[6] Univ Cattolica Sacro Cuore, Gynecol Oncol Unit, IRCCS, Fdn Policlin Gemelli, Rome, Italy
[7] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Obstet & Gynecol, Seoul, South Korea
[8] Vall dHebron Inst Oncol VHIO, Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
[9] Univ New South Wales, Prince Wales Hosp, Sch Clin, Dept Med Oncol, Randwick, NSW, Australia
[10] St Petersburg City Oncol Dispensary, Dept Gynaecol Oncol, St Petersburg, Russia
[11] Inst Bergonie, Ctr Comprehens Canc, Oncol Med, Bordeaux, France
[12] Grp Investi Nationaux Etude Cancers Ovariens, Bordeaux, France
[13] Inst Gustave Roussy, Gynecol Unit, Villejuif, France
[14] Grp Invest Nationaux Etude Cancers Ovariens, Villejuif, France
[15] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[16] Univ Edinburgh, Nicola Murray Ctr Ovarian Canc Res, Canc Res UK Edinburgh Ctr, Edinburgh, Midlothian, Scotland
[17] Princess Margaret Canc Ctr, Med Oncol & Hermatol, Toronto, ON, Canada
[18] Clin Univ Navarra, Dept Med Oncol, Madrid, Spain
[19] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
[20] Froedtert, Dept Obstet & Gynecol, Milwaukee, WI USA
[21] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[22] AstraZeneca, Oncol Res & Dev Unit, Cambridge, England
[23] Astra Zeneca, Global Med Dev, Gaithersburg, MD USA
[24] Women & Infants Hosp Rhode Isl, Div Gynecol Oncol, Providence, RI USA